Picture of ImmuCell logo

ICCC — ImmuCell News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: ImmuCell Says Expects To Reduce Backlog Of Orders During Q3

July 7 (Reuters) - ImmuCell Corp  ICCC.O :
    * IMMUCELL ANNOUNCES STRONG PRELIMINARY, UNAUDITED SALES
RESULTS
FOR SECOND QUARTER OF 2021
    * IMMUCELL CORP - EXPECT TO SIGNIFICANTLY REDUCE OR
ELIMINATE
BACKLOG OF ORDERS DURING Q3
    * IMMUCELL CORP - BACKLOG OF ORDERS INCREASED TO ABOUT $3.1
MILLION AS OF MARCH 31, 2021 FROM ABOUT $1.8 MILLION AS OF
DECEMBER 31, 2020
    * IMMUCELL - EXPECT TO REPORT A 53% INCREASE IN TOTAL
PRODUCT
SALES TO ABOUT $4.5 MILLION FOR QUARTER ENDED JUNE 30, 2021
    * IMMUCELL CORP - EXPECT TO REPORT THAT CO SHIPPED 11% MORE
PRODUCT DURING Q2 2021 THAN Q1

Source text for Eikon:  ID:nGNXQ7yQR 
Further company coverage:  ICCC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on ImmuCell

See all news